# An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer (AXIOM)

> **NCT01697462** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 258 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01697462
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2016-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01697462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01697462, "An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer (AXIOM)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01697462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*